DRAXIS Specialty Pharmaceuticals

DRAXIS Specialty Pharmaceuticals, a subsidiary of Jubilant Pharmova, is a Canadian-based pharmaceutical company specializing in radiopharmaceuticals and contract manufacturing services. The company operates through two primary business units: Jubilant DraxImage, which focuses on diagnostic and therapeutic radiopharmaceuticals for nuclear medicine, and Jubilant HollisterStier, which provides contract manufacturing for sterile and non-sterile products. Their product portfolio includes imaging agents for various medical conditions, including lung, liver, and kidney disorders, as well as thyroid cancer treatments. With a significant manufacturing facility in Kirkland, Quebec, DRAXIS serves a global market, providing critical medical isotopes and specialized drug delivery formats like lyophilized vials. The company is recognized for its expertise in technetium-99m generators and specialized imaging agents used in oncology, cardiology, and neurology.